Clinical Trials
26 trialsPRO-NEM1
Centre Hospitalier Universitaire Dijon
iCaRe2
University of Nebraska
Project: Every Child for Younger Patients With Cancer
Children's Oncology Group
Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior Treatment
Ipsen
PRRT
Methodist Health System
Management of Pancreatic Cystic Lesions Using Artificial Intelligence Based on EUS and Multimodal Data
Huazhong University of Science and Technology
FARINET
IRCCS San Raffaele
DENUTNE
University Hospital, Strasbourg, France
Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC)
National Institutes of Health Clinical Center (CC)
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
AURA-RIV-TNE
Hospices Civils de Lyon
TAILOR-EUS
IRCCS San Raffaele
18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis
Nanjing First Hospital, Nanjing Medical University
REBORN
University of Roma La Sapienza
ANZ UGI
Western Sydney Local Health District
JPET2Clinic
Jagiellonian University
EpigenOMic Determinants of the Neuroendocrine Phenotype As Biomarkers for Neuroendocrine Neoplasms
European Institute of Oncology
Protein Molecular Characteristics and Prognosis of Cervical Neuroendocrine Tumors
Fujian Maternity and Child Health Hospital
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients
Universidad Nacional Autonoma de Mexico
ETNA-FPG
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
TAPIOCA
European Institute of Oncology
YOUNGSTER
European Institute of Oncology
Predictive Value of Serum and Tissue Molecular Markers and Imaging Features in the Invasiveness and Prognosis of Pituitary Neuroendocrine Tumors
Sun Yat-sen University
68Ga-HA-DOTATATE PET/CT in Adults With Neuroendocrine Tumors
Alberta Health services
SEPTRALU
Sociedad Española de Medicina Nuclear e Imagen Molecular
SwissNET
Insel Gruppe AG, University Hospital Bern